$0.37
Purple Biotech is a biotechnology business based in the US. Purple Biotech shares (PPBT) are listed on the NASDAQ and all prices are listed in US Dollars. Purple Biotech employs 20 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Purple Biotech stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- No-cost financial planning and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Purple Biotech stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PPBT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Purple Biotech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Purple Biotech stock price (NASDAQ: PPBT)
Use our graph to track the performance of PPBT stocks over time.Purple Biotech shares at a glance
Latest market close | $0.36 |
---|---|
52-week range | $0.30 - $1.80 |
50-day moving average | $0.53 |
200-day moving average | $0.75 |
Wall St. target price | $8.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.79 |
Is it a good time to buy Purple Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Purple Biotech price performance over time
Historical closes compared with the close of $0.3558 from 2024-07-23
1 week (2024-07-17) | -7.00% |
---|---|
1 month (2024-06-24) | -31.79% |
3 months (2024-04-24) | -30.60% |
6 months (2024-01-24) | -42.33% |
1 year (2023-07-24) | -70.10% |
---|---|
2 years (2022-07-22) | -85.11% |
3 years (2021-07-23) | 4.95 |
5 years (2019-07-24) | 0.8501 |
Purple Biotech financials
Gross profit TTM | $-120,000 |
---|---|
Return on assets TTM | -29.07% |
Return on equity TTM | -48.26% |
Profit margin | 0% |
Book value | $1.14 |
Market Capitalization | $12.6 million |
TTM: trailing 12 months
Purple Biotech share dividends
We're not expecting Purple Biotech to pay a dividend over the next 12 months.
Have Purple Biotech's shares ever split?
Purple Biotech's shares were split on a 1:10 basis on 20 August 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Purple Biotech shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Purple Biotech shares which in turn could have impacted Purple Biotech's share price.
Purple Biotech share price volatility
Over the last 12 months, Purple Biotech's shares have ranged in value from as little as $0.3023 up to $1.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Purple Biotech's is 0.383. This would suggest that Purple Biotech's shares are less volatile than average (for this exchange).
Purple Biotech overview
Purple Biotech Ltd. , a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.
Frequently asked questions
What percentage of Purple Biotech is owned by insiders or institutions?Currently 3.429% of Purple Biotech shares are held by insiders and 8.669% by institutions. How many people work for Purple Biotech?
Latest data suggests 20 work at Purple Biotech. When does the fiscal year end for Purple Biotech?
Purple Biotech's fiscal year ends in December. Where is Purple Biotech based?
Purple Biotech's address is: 4 Oppenheimer Street, Rehovot, Israel, 7670104 What is Purple Biotech's ISIN number?
Purple Biotech's international securities identification number is: US74638P1093
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question